UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Russian military losses updated on day 1729

Aliyev congratulates Sultan of Oman on National Day

Temperatures to reach 21°C in Baku on November 19

Aliyev congratulates Latvian President on Independence Day

Rovshan Askerov to face trial in absentia in Russia

Pakistani man sentenced to 27 years for plot to kill Trump

Xi welcomes Trump in Shenzhen - Video

TRIPP technical working group began work on November 6

US Navy used expired munitions in Iran war

Azerbaijan-Turkiye relations will remain strong in the future

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla